AEterna Zentaris Inc. is a listed company. Its insiders report their share dealings to SEDI. AEterna Zentaris Inc. has had no insider filing for more than a year; the last one goes back to 7 June 2024.
The full history, which starts in 2016, counts 22 purchases against 2 sales.
Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 45 declarations
AEterna Zentaris Inc. is a biopharmaceutical company focused on developing treatments for endocrine and oncological diseases. It is listed on the Toronto Stock Exchange under the symbol XTSE.